The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Jan Apelqvist

Physician

Default user image.

Assessment of autonomic symptoms in diabetics: the Swedish version of the Autonomic Symptom Profile.

Author

  • Thomas Mandl
  • Viktoria Granberg
  • Jan Apelqvist
  • Per Wollmer
  • Rolf Manthorpe
  • Lennart Jacobsson

Summary, in English

Objectives: Autonomic dysfunction (AD) is a complication of diabetes and may be associated with troubling symptoms and increased mortality. Commonly, AD is detected by objective physiological tests and only recently, a validated self-completed English questionnaire assessing AD symptoms, the Autonomic Symptom Profile (ASP), was developed. The aims of this study were to translate the ASP into Swedish and evaluate its reliability and validity. Methods: Forward and back translations were performed. Thirty-one patients with type I diabetes, 200 population-based controls and two AD experts participated in the study. Test-retest reliability was evaluated by letting 25 patients to fill in the ASP twice. Content validity was evaluated by two Swedish AD experts and construct validity was evaluated by studying associations between the ASP total score and five objective autonomic nervous function test variables. Finally, discriminant validity was evaluated by studying differences in the ASP total and domain scores between patients and controls. Results: The translation was accepted without changes. Test-retest reliability and content validity of the Swedish ASP were considered good. The construct validity was considered acceptable with two significant associations between the ASP total score and the autonomic nervous function test variables. In addition, discriminant validity was considered acceptable with regard to the ASP total score as well as the sexual dysfunction, sleep disorder and vasomotor dysfunction domain scores significantly differing between patients and controls. Conclusion: The Swedish version of the ASP was considered a reliable and valid instrument for the study of AD symptoms in patients with type I diabetes.

Department/s

  • Internal Medicine - Epidemiology
  • Department of Clinical Sciences, Malmö
  • Clinical Physiology, Malmö
  • Rheumatology

Publishing year

2008

Language

English

Pages

312-317

Publication/Series

Clinical Physiology and Functional Imaging

Volume

28

Document type

Journal article

Publisher

John Wiley and Sons

Topic

  • Physiology

Status

Published

Research group

  • Internal Medicine - Epidemiology
  • Clinical Physiology, Malmö

ISBN/ISSN/Other

  • ISSN: 1475-0961